sofidexFor patientsAre you a clinician? Clinical site
Ask Sofi
Listen
Patient SupportEmergencies & Reporting
Log inSign up

Meds & supplements  ›  Edaravone

Medicine

Edaravone

RADICAVA and RADICAVA ORS are indicated for the treatment of amyotrophic lateral sclerosis (ALS).

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
RADICAVA and RADICAVA ORS are indicated for the treatment of amyotrophic lateral sclerosis (ALS).
Do not take if
  • Edaravone injection is contraindicated in patients with a history of hypersensitivity to edaravone or any of the inactive ingredients in this product.
  • Hypersensitivity reactions and anaphylactic reactions have occurred.

What it is used for

Edaravone injection is indicated for the treatment of amyotrophic lateral sclerosis (ALS).

Side effects, and when to stop

The following serious adverse reactions are described elsewhere in the labeling:

Who should not take it

Edaravone injection is contraindicated in patients with a history of hypersensitivity to edaravone or any of the inactive ingredients in this product. Hypersensitivity reactions and anaphylactic reactions have occurred.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Edaravone; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/edaravone

APA 7th

sofidex. (2026, August 2). Edaravone. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/edaravone

AMA 11th

Edaravone. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/edaravone

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.